论文部分内容阅读
胰腺炎是内镜逆行胰胆管造影术(ERCP)的术后常见并发症。ERCP患者的选择和术前评估相关危险因素是预防ERCP术后胰腺炎(PEP)的关键。胰管支架对预防PEP有一定作用,但具有局限性。NSAIDs直肠给药是降低PEP发生率的有效方式。其余药物预防PEP的结论尚不明确。本文就PEP的研究进展作一综述。
Pancreatitis is a common postoperative complications of endoscopic retrograde cholangiopancreatography (ERCP). The selection of ERCP and the risk factors associated with preoperative evaluation are key to preventing post-ERCP pancreatitis (PEP). Pancreatic duct stent to prevent PEP has a certain role, but has its limitations. Rectal administration of NSAIDs is an effective way to reduce the incidence of PEP. The conclusions of the remaining drugs to prevent PEP is not yet clear. This article reviews the research progress of PEP.